New regional partnership strengthens Nanox’s presence and repair help throughout outpatient imaging settings in Colorado, Wyoming and the western elements of Kansas and Nebraska
Settlement aligns with Nanox’s technique to increase by means of regional distributors with sturdy industrial attain and repair infrastructure
PETACH TIKVA, Israel, April 2, 2026 (GLOBE NEWSWIRE) — Nano-X Imaging Ltd. (NASDAQ: NNOX), a frontrunner in progressive medical imaging know-how, immediately introduced that its U.S.-based subsidiary, Nanox Impression Inc., has signed a brand new distribution settlement with Integrity Medical Service Inc., a Colorado primarily based supplier of imaging options serving hospitals, orthopedic practices, imaging facilities, and outpatient suppliers.
Below the phrases of the settlement, Integrity Medical Service will lead gross sales, implementation and repair help for the Nanox.ARC system all through Colorado, Wyoming and the western elements of Kansas and Nebraska.
The collaboration is anticipated to increase Nanox’s presence within the area whereas leveraging Integrity’s established relationships throughout the native imaging neighborhood. The goal can be to deploy 4 programs in Yr 1 and 12 in Yr 2, topic to market situations and buyer adoption.
More Read
Integrity Medical Service operates with a service pushed mannequin supported by a devoted workforce of subject service engineers, enabling ongoing buyer help, system uptime, and scientific continuity. This infrastructure positions the corporate to help environment friendly deployment and long-term use of superior imaging options throughout outpatient settings.
Erez Meltzer, Chief Government Officer and Appearing Chairman of Nanox, mentioned: “We are pleased to welcome Integrity Medical Service to our growing network of U.S. distribution partners. Integrity Medical Service’s established presence in Colorado and service focused model aligns well with our regional strategy and support reliable implementation and long-term utilization of the Nanox.ARC system.”
Paul Proffit, President of Integrity Medical Service, added: “We see strong demand for imaging solutions that support orthopedic and outpatient workflows while maintaining high service standards. The Nanox.ARC multisource digital tomosynthesis system leverages Nanox’s proprietary X ray source technology to enable 3D imaging in a wide range of clinical environments, including outpatient and community-based settings. Partnering with Nanox allows us to bring the Nanox.ARC system to our customers while leveraging our service infrastructure to support long term adoption.”
More Read
The settlement helps Nanox’s broader technique of partnering with regional distributors that mix industrial attain with sturdy service capabilities to drive adoption and sustained utilization.
About Nanox
Nanox (NASDAQ: NNOX) is targeted on driving the world’s transition to preventive well being care by delivering an built-in, end-to-end medical imaging and healthcare providers platform.
Nanox combines reasonably priced imaging {hardware}, superior AI-based options, cloud-based software program, entry to distant radiology, well being IT options, and a market to allow earlier detection, improved scientific effectivity, and broader entry to care.
Nanox’s imaginative and prescient is to increase the attain of medical imaging each inside and past conventional hospital settings by offering a seamless resolution from scan to interpretation and past. By leveraging proprietary digital X-ray know-how, AI-driven analytics, and a clinically pushed method, Nanox goals to reinforce the effectivity of routine imaging workflows, help early detection of illness, and enhance affected person outcomes.
The Nanox ecosystem contains Nanox.ARC, a cheap, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability; Nanox.AI, a collection of AI-based algorithms that increase the interpretation of routine CT imaging to determine early indicators typically related to power illness; Nanox.CLOUD, a cloud-based platform for safe knowledge administration, storage, and superior imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which give entry to distant radiology and cardiology consultants and complete teleradiology providers; and Nanox Well being IT, which mixes deep healthcare IT experience with main know-how companions to ship RIS, PACS, AI, dictation, and safe infrastructure options that streamline workflows and help safer, extra environment friendly care supply.
More Read
By integrating imaging know-how, AI, cloud infrastructure, scientific experience, a market, and well being data know-how, Nanox seeks to decrease boundaries to adoption, enhance utilization, and advance preventive care worldwide. For extra data, please go to www.nanox.imaginative and prescient
Ahead-Trying Statements
This press launch might comprise forward-looking statements which might be topic to dangers and uncertainties. All statements that aren’t historic info contained on this press launch are forward-looking statements. Such statements embrace, however usually are not restricted to, any statements referring to the initiation, timing, progress and outcomes of the Firm’s analysis and growth, manufacturing, and commercialization actions with respect to its X-ray supply know-how and the Nanox.ARC, the power to appreciate the anticipated advantages of its current acquisitions and the projected enterprise prospects of the Firm and the acquired corporations. In some circumstances, you may determine forward-looking statements by terminology reminiscent of “can,” “might,” “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “should,” “could,” “expect,” “predict,” “potential,” or the damaging of those phrases or different comparable expressions. Ahead-looking statements are primarily based on data the Firm has when these statements are made or administration’s good religion perception as of that time with respect to future occasions and are topic to dangers and uncertainties that would trigger precise efficiency or outcomes to vary materially from these expressed in or recommended by the forward-looking statements. Elements that would trigger precise outcomes to vary materially from these at the moment anticipated embrace: dangers associated to (i) Nanox’s skill to finish growth of the Nanox System; (ii) Nanox’s skill to efficiently show the feasibility of its know-how for industrial functions; (iii) Nanox’s expectations concerning the need of, timing of submitting for, and receipt and upkeep of, regulatory clearances or approvals concerning its know-how, the Nanox.ARC and Nanox.CLOUD from regulatory companies worldwide and its ongoing compliance with relevant high quality requirements and regulatory necessities; (iv) Nanox’s skill to appreciate the anticipated advantages of the acquisitions, which can be affected by, amongst different issues, competitors, model recognition, the power of the acquired corporations to develop and handle progress profitably and retain their key staff; (v) Nanox’s skill to enter into and preserve commercially cheap preparations with third-party producers and suppliers to fabricate the Nanox.ARC; (vi) the market acceptance of the Nanox System and the proposed pay-per-scan enterprise mannequin; (vii) Nanox’s expectations concerning collaborations with third-parties and their potential advantages; (viii) Nanox’s skill to conduct enterprise globally; (ix) modifications in international, political, financial, enterprise, aggressive, market and regulatory forces; (x) dangers associated to the present battle between Israel and Hamas and any worsening of the scenario in Israel; (xi) dangers associated to enterprise interruptions ensuing from the COVID-19 pandemic or comparable public well being crises, amongst different issues; and (xii) potential litigation related to our transactions.
For a dialogue of different dangers and uncertainties, and different necessary components, any of which might trigger Nanox’s precise outcomes to vary from these contained within the Ahead-Trying Statements, see the part titled “Risk Factors” in Nanox’s Annual Report on Kind 20-F for the 12 months ended December 31, 2024, and subsequent filings with the U.S. Securities and Trade Fee. The reader shouldn’t place undue reliance on any forward-looking statements included on this press launch. Besides as required by regulation, Nanox undertakes no obligation to replace publicly any forward-looking statements after the date of this press launch to adapt these statements to precise outcomes or to modifications within the Firm’s expectations.
Contacts
